Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
75 Leser
Artikel bewerten:
(0)

Pro-Trader Daily: Earnings Review and Free Research Report: Kimberly-Clark Reported Q2 Results and Updated its 2017 Outlook

Research Desk Line-up: Procter & Gamble Post Earnings Coverage

LONDON, UK / ACCESSWIRE / August 2, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Kimberly-Clark Corp. (NYSE: KMB), which can be viewed by registering at http://protraderdaily.com/optin/'symbol=KMB, following the Company's reporting of its financial results on July 25, 2017, for Q2 FY17. The Company reported a decrease of net sale of 1% y-o-y along with a 1% decrease in organic sales on a y-o-y basis. Our daily stock reports are accessible for free, and with those to look forward today you also will be signing up for a complimentary member's account at:

http://protraderdaily.com/register/

Get more of our free earnings reports coverage from other constituents of the Personal Products industry. Pro-TD has currently selected The Procter & Gamble Company (NYSE: PG) for due-diligence and potential coverage as the Company announced on July 27, 2017, its financial results for Q4 FY17 and FY17. Register for a free membership today, and be among the early birds that get access to our report on Procter & Gamble when we publish it.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on KMB; also brushing on PG. With the links below you can directly download the report of your stock of interest free of charge at:

http://protraderdaily.com/optin/'symbol=KMB

http://protraderdaily.com/optin/'symbol=PG

Earnings Reviewed

Kimberly-Clark generated net sale of $4.55 billion for Q2 FY17 compared to $4.59 billion for Q2 FY16; noting a decrease of 0.8% y-o-y. The operating profit for Q2 FY17 was $799 million compared to $838 million for Q2 FY16; a decrease of 4.7% y-o-y.

The net income for Q2 FY17 was $540 million compared to $578 million in Q2 FY16; reflecting a drop of 6.6% y-o-y. Kimberly-Clark's net diluted earnings per share (EPS) in Q2 FY17 was $1.49 compared to $1.56 for Q2 FY16; a decrease of 4.5% y-o-y. Cash dividend declared for Q2 FY17 was $0.97 compared to $0.92 in Q2 FY16; an increase of 5.4% y-o-y.

The Company nearly met analysts' consensus estimates of $1.50 per share for Q2 FY17, while it fell short of revenues' estimates pegged at $4.58 billion for the reported quarter.

Segment Information

In Q2 FY17, Kimberly-Clark's personal care segment generated net sale of $2.27 billion compared to $2.28 billion in Q2 FY16; a slight decrease of 0.4% y-o-y. The segment also saw operating profit of $467 million in the reported quarter compared to $455 million in Q2 FY16; noting an increase of 2.6% y-o-y.

In the Consumer Tissue segment, Kimberly-Clark generated net sale of $1.46 billion in Q2 FY17 compared to $1.49 billion in Q2 FY16; noting a decrease of 2% y-o-y. The segment also saw an operating profit of $241 million in Q2 FY17 compared to $275 million in Q2 FY16; a decrease of 12.4% y-o-y.

In its K-C- Professional segment, the Company generated net sales of $810 million in Q2 FY17 compared to $806 million in Q2 FY16; noting a slight rise of 0.5% y-o-y. The segment also saw an operating profit of $163 million in Q2 FY17 compared to $150 million in Q2 FY16; an increase of 8.7% y-o-y.

Kimberly-Clark's Corporate and Other segment generated net sale of $11 million in Q2 FY17 compared to$9 million in Q2 FY16; noting an increase of 22.2% y-o-y. The segment also saw an operating loss of $69 million in Q2 FY17 compared to an operating loss of $63 million in Q2 FY16, reducing the loss by 9.5% y-o-y.

Cash Matters

Kimberly-Clark generated $825 million in cash from operations in Q2 FY17 compared to $860 million in Q2 FY16, marking a fall of 4.1% y-o-y. The Company stated that higher tax payments and lower earnings impacted this change in Q2 FY17, while working capital improved. In Q2 FY17, capital spending was $171 million compared to $177 million in Q2 FY16; noting a decrease of 3.4% y-o-y.

The Company also spent $300 million for share repurchases of 2.3 million shares in Q2 FY17. The total debt stood at $8.0 billion at June 30, 2017, compared to $7.6 billion at the end of 2016.

Outlook

The Company updated a few planning and guidance assumptions for the full-year 2017 including expected net sales and organic sales being similar, or up slightly, on a y-o-y basis; sale volumes anticipated to be up slightly, while net selling prices and product mix, combined, are expected to be down slightly.

Kimberly-Clark also estimated an input cost inflation of $200 million to $300 million compared to the previous estimate of $150 million to $250 million, driven by higher assumptions for pulp costs. The Company has also updated anticipated cost savings of $425 million to $450 million from the company's FORCE program compared to the prior estimate for savings of at least $400 million. Kimberly-Clark also anticipates EPS to be at the low-end of the target range of $6.20 to $6.35.

Stock Performance

On Tuesday, August 01, 2017, the stock closed the trading session at $121.69, falling 1.19% from its previous closing price of $123.16. A total volume of 1.65 million shares have exchanged hands, which was higher than the 3-month average volume of 1.59 million shares. Kimberly-Clark's stock price advanced 0.46% in the past six months. Furthermore, since the start of the year, shares of the Company have gained 6.63%. The stock is trading at a PE ratio of 20.34 and has a dividend yield of 3.19%. At Tuesday's closing price, the stock's net capitalization stands at $43.61 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.